Ignite Creation Date:
2025-12-25 @ 2:47 AM
Ignite Modification Date:
2026-04-17 @ 5:52 PM
Study NCT ID:
NCT02135133
Status:
COMPLETED
Last Update Posted:
2024-10-16
First Post:
2014-04-24
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Idelalisib (GS1101, CAL101) + Ofatumumab in Previously Untreated CLL/SLL
Sponsor:
Dana-Farber Cancer Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-06
Start Date Type:
None
Primary Completion Date:
2020-10-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-10-06
Completion Date Type:
ACTUAL
First Submit Date:
2014-04-24
First Submit QC Date:
None
Study First Post Date:
2014-05-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2024-08-28
Results First Submit QC Date:
None
Results First Post Date:
2024-10-16
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-14
Last Update Post Date:
2024-10-16
Last Update Post Date Type:
ACTUAL